Group 1 - Tecan Group successfully raised CHF 150 million through the issuance of a fixed rate domestic straight bond with a coupon of 0.850% and a duration of 5 years [1][2] - The net proceeds from the bond issuance will be used for general corporate purposes, including the repayment of an outstanding CHF 250 million bond maturing in October 2025 [2] - The bonds were placed with institutional investors and private banks in Switzerland, managed by UBS Investment Bank and Zürcher Kantonalbank, with Bank J. Safra Sarasin as Co-Lead Manager [2] Group 2 - Tecan is a global leader in laboratory automation, improving healthcare innovation from life science to clinical applications [3] - Founded in Switzerland in 1980, Tecan has over 3,000 employees and operates manufacturing, research, and development sites in Europe, North America, and Asia [3] - In 2024, Tecan generated sales of CHF 934 million (USD 1,062 million; EUR 984 million) [3]

Core Points - Tecan Group AG will hold a conference call to discuss its financial results for the first half of 2025 on August 12, 2025, at 08:30 CEST [1] - The financial results will be published on the same day at 6:00 CEST, and the conference call will be available as an audio-webcast with synchronized presentation slides [1] - The full 2025 Interim Report will be accessible on Tecan's website under the Investor Relations section on August 12 [3] Company Overview - Tecan is a pioneer and global leader in laboratory automation, improving lives and health by empowering customers to scale healthcare innovation globally [4] - Founded in Switzerland in 1980, Tecan has over 3,000 employees and operates manufacturing, research, and development sites in Europe, North America, and Asia, with a sales and service network in over 70 countries [4] - In 2024, Tecan generated sales of CHF 934 million (approximately USD 1,062 million; EUR 984 million) [4]